Paraza Pharma is ISO 27001:2013 Certified
We are proud to announce that Paraza Pharma, Inc. has recently achieved ISO 27001:2013 (ISO 27001) certification, one of the most globally recognized information security standards.
ISO 27001 is the international standard that sets out the specification for an Information Security Management System (ISMS).
Paraza Lecture Series
We are honored to welcome Professor Michel Gravel at Paraza Pharma.
Paraza Pharma Publications
Paraza has recently published some useful abstracts in the Heterocycles portion of SYNFACTS (Thieme Chemistry). This is an ongoing collaboration with Dr. Mark Reed at the Krembil Research Institute in Toronto to highlight useful methodologies in the recent literature for constructing pharmacologically relevant architectures.
Paraza Pharma appoints Dr. Chudi Nbubaku
Paraza Pharma appoints Dr. Chudi Nbubaku as CSO.
CIC Chair’s and CSC President’s Awards Ceremony
Dr. Alexandre Larivée, Executive Director – Chemical Sciences at Paraza Pharma, presented the Bernard Belleau Award to Professor Gonzalo Cosa at the CIC Chair’s and CSC President’s Awards Ceremony.
BIO International Conference
Paraza Pharma will be attending the BIO International Conference from June 13-16, 2022 in San Diego, CA.
Paraza Pharma supports an annual lecture
Paraza Pharma supports an annual lecture at the Université de Montréal.
Paraza Pharma Publications
Paraza has recently published some useful abstracts in the Heterocycles portion of SYNFACTS (Thieme Chemistry). This is an ongoing collaboration with Dr. Mark Reed at the Krembil Research Institute in Toronto to highlight useful methodologies in the recent literature for constructing pharmacologically relevant architectures.
Paraza Pharma Publications
Paraza has recently published some useful abstracts in the Heterocycles portion of SYNFACTS (Thieme Chemistry). This is an ongoing collaboration with Dr. Mark Reed at the Krembil Research Institute in Toronto to highlight useful methodologies in the recent literature for constructing pharmacologically relevant architectures.
Paraza Pharma Publications
Paraza has recently published some useful abstracts in the Heterocycles portion of SYNFACTS (Thieme Chemistry). This is an ongoing collaboration with Dr. Mark Reed at the Krembil Research Institute in Toronto to highlight useful methodologies in the recent literature for constructing pharmacologically relevant architectures.